TY  - GEN
AU  - Kissling, Esther
AU  - Rose, Angela Mc
AU  - Emborg, Hanne-Dorthe
AU  - Gherasim, Alin Manuel
AU  - Pebody, Richard
AU  - Pozo Sanchez, Francisco
AU  - Trebbien, Ramona
AU  - Mazagatos, Clara
AU  - Whitaker, Heather
AU  - Valenciano, Marta
AU  - European IVE group
AU  - Larrauri, Amparo
AU  - Casas Flecha, Inmaculada
AU  - Delgado-Sanz, Concepcion
AU  - Oliva Dominguez, Jesus Angel
PY  - 2019
DO  - 10.2807/1560-7917.ES.2019.24.1900121
SN  - 1560-7917
UR  - http://hdl.handle.net/20.500.12105/8980
AB  - Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018-January 2019. Interim results from six studies indicate that 2018/19 influenza vaccine effectiveness (VE) estimates among all ages in primary care was 32-43% against...
LA  - eng
PB  - European Centre for Disease Prevention and Control (ECDC)
KW  - Europe
KW  - Influenza
KW  - Multicentre study
KW  - Test-negative design
KW  - Vaccination
KW  - Vaccine effectiveness
KW  - Vaccines and immunisation
TI  - Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019
TY  - research article
ER  -